July 25, 2019

BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA

BAQSIMI is expected to be available in U.S. pharmacies within one month INDIANAPOLIS, July 24, 2019 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal … Continued